Plasma lipoprotein lipase, hepatic lipase activities, VLDL, LDL compositions at different times of hemodialysis

Atherosclerosis

Volumn 169, Issue 2, 2003, Pages 269-277

  Mekki, Khedidja ^a   Prost, Josiane ^b   Bouchenak, Malika ^a   Remaoun, Mustapha ^c   Belleville, Jacques ^b  

^a UNIVERSITY OF ORAN   (Algeria)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c Service d'anatomie pathologique   (Algeria)

Author keywords

CRF; Hemodialysis duration; Hepatic lipase; Hypertriglyceridemia; Lipoprotein lipase; VLDL LDL

Indexed keywords

ACETIC ACID; APOLIPOPROTEIN; APOLIPOPROTEIN C3; CHOLESTEROL ESTER; CUPROPHANE; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMODIALYSIS; HUMAN; LIPID COMPOSITION; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0142061120     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00011-X     Document Type: Article

References (31)

1. Eckel R.H. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. New Engl. J. Med. 320:1989;1060-1068.
2. Demant T., Carlson L.A., Holmquist L., Karpe F., Nilsson-Ehle P., Packard C.J., Shepherd J. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and the effect of hepatic lipase on high density lipoprotein. J. Lipid Res. 29:1989;1603-1611.
3. Appel G. Lipid abnormalities in renal disease. Kidney Int. 39:1991;169-183.
4. Lindner A., Charra B., Sherrad D., Scribnner B.H. Accelerated atherosclerosis in prolonged maintenance hemodialysis. New Engl. J. Med. 290:1974;697-701.
5. Ma K.V., Green E.L., Raij L. Cardiovascular risk factors in the chronic renal failure and hemodialysis population. Am. J. Kidney Dis. 19:1992;505-513.
6. Attman P.O., Samuelson O., Alaupovic P. Lipoprotein metabolism and renal failure. Am. J. Kidney Dis. 21:1993;573-592.
7. Alsayed N., Rebourcet R. Abnormal concentrations of CII, CIII and E apolipoproteins among apolipoprotein B-containing, B-free, and A-I containing lipoprotein particles in hemodialysis patients. Clin. Chem. 37:1993;387-393.
8. Arnadottir M., Thysell H., Dallongeville J., Fruchart J.C., Nilsson-Ehle P. Evidence that reduced lipoprotein lipase activity is not a primary pathogenic factor for hypertriglyceridemia in renal failure. Kidney Int. 48:1995;779-784.
9. Vaziri N.D., Liang K. Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. Kidney Int. 50:1996;1928-1935.
10. Arnadottir M., Kurkus J., Nilsson-Ehle P. Different types of heparin in hemodialysis. Long-term effects on post-heparin lipases. Scand. J. Clin. Lab. Invest. 54:1994;515-521.
11. Cheung A.K., Parker C.J., Ren K., Henrik-Iverius P. Increased lipase inhibition in uremia: identification of pre-βHDL as a major inhibitor in normal and uremic plasma. Kidney Int. 49:1996;1360-1371.
12. Schort C.D., Durrington P.N. Hyperlipidemia and renal disease. Clin. Endocrinol. Metab. 4:1990;777-806.
13. Elisaf M.S., Bairaktari H.T., Tziallas C.S., Germanos N.K., Siamopoulos K.C. Atherogenic lipid and lipoprotein parameters in hemodialysis patients. Dial. Trans. 24:1995;642-660.
14. Bories P.C., Subbaiah P.V., Bagdade J.D. Lecithin-cholesterol-acyl- transferase activity in dialyzed chronic uremic patients. Nephron. 32:1982;22-27.
15. Senti M., Romero R., Pedro-Botet J., Pelegri A., Noguès X., Rubiès-Prat J. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int. 41:1992;1394-1399.
16. Ponticelli C., Barbi G., Cataluppi A., Donati C., Annoni G., Brancacci D. Lipid abnormalities in maintenance dialysis patients and renal transplant patients. Kidney Int. 13:1978;5-578.
17. Nilsson-Ehle P., Ekman R. Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase. Artery. 3:1977;194-209.
18. Nilsson-Ehle P., Schotz M.C. A stable radioactive substrate emulsion for assay of lipoprotein lipase. J. Lipid Res. 17:1976;536-541.
19. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1955;1345-1353.
20. Redgrave T.G., Roberts D.C.K., West C.E. Separation of plasma lipoprotein gradient ultracentrifugation. Anal. Biochem. 65:1987;42-49.
21. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.I. Protein measurement with the folin reagent. J. Biol. Chem. 193:1951;265-275.
22. 13C] cholesterol as internal standard. J. Chromatogr. 162:1979;1-6.
23. Gambert P., Lallemant C., Athias A., Padieu P. Alteration of HDL cholesterol distribution induced by incubation of human serum. Biochim. Biophys. Acta. 713:1982;1-9.
24. Macheboeuf M., Delsal J. Determination of small quantities of phosphorus inorganic natural. Bull. Soc. Chim. Biol. 25:1943;116-125.
25. Irwin D., O'Lonney P.A., Quinet E., Vahouny G.V. Application of SDS gradient polyacrylamide gel electrophoresis to analysis of apolipoprotein mass and radioactivity of lipoproteins. Atherosclerosis. 53:1984;163-172.
26. Joven J., Vilella E., Ahmad S., Cheung M.C., Brunzell J.D. Lipoprotein heterogeneity in end stage renal disease. Kidney Int. 43:1993;410-418.
27. Thuren T., Wilcox R.W., Sisson P., Waite M. Hepatic lipase hydrolysis of lipid monolayers. Regulation by apolipoproteins. J. Biol. Chem. 266:1991;4853-4861.
28. Seres D.S., Strain G.W., Hashim S.A., Goldberg I.J., Levin N.W. Improvement of plasma lipoprotein profiles during high-flux dialysis. J. Am. Soc. Nephrol. 3:1993;1409-1415.
29. Alhomida A.S. Influence of acetate and bicarbonate dialysate on blood short-and long-chain acyl carnitine in adult pyelonephritis. Ann. Clin. Biochem. 36:1999;48-55.
30. Docci D., Capponcini C., Mengozzi S., Baldrati L., Neri L., Feletti C. Effects of different dialysis membranes on lipid and lipoprotein serum profiles in hemodialysis patients. Nephron. 69:1995;323-326.
31. Schrander V.D., Meer A.M., TerWee P.M., Kan G., Donker A.J., Van Dorp W.T. Improved cardiovascular variables during acetate free biofiltration. Clin. Nephrol. 51:1999;5304-5309.